KR20100073987A - Liquid preparation reducing unpleasant taste and bad smell - Google Patents

Liquid preparation reducing unpleasant taste and bad smell Download PDF

Info

Publication number
KR20100073987A
KR20100073987A KR1020090116597A KR20090116597A KR20100073987A KR 20100073987 A KR20100073987 A KR 20100073987A KR 1020090116597 A KR1020090116597 A KR 1020090116597A KR 20090116597 A KR20090116597 A KR 20090116597A KR 20100073987 A KR20100073987 A KR 20100073987A
Authority
KR
South Korea
Prior art keywords
vitamin
unpleasant taste
thiamine
acid
smell
Prior art date
Application number
KR1020090116597A
Other languages
Korean (ko)
Inventor
카즈코 카네코
히로유키 야마다
Original Assignee
에스에스 세야쿠 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스에스 세야쿠 가부시키 가이샤 filed Critical 에스에스 세야쿠 가부시키 가이샤
Publication of KR20100073987A publication Critical patent/KR20100073987A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE: An internal medicine containing vitamin B1 of which unpleasant taste and smell are reduced is provided to ensure pharcological action and to use as soft drink and non-medical supplies. CONSTITUTION: An internal medicine contains vitamin B1 of which unpleasant taste and smell are reduced. The vitamin B1 includes thiamine, thiamine nitrate, thiamine sulfide nitrae(bithiamine nitrate), thiamine sulfide, thiamine di cetyl sulfate salt, dicethiamine hydrochloride, fursultiamine hydrochloride, and fursultiamine. The internal medicine contains water, ethanol, propylene glycol, or glycerin.

Description

불쾌한 맛 및 냄새가 저감된 내복액제{LIQUID PREPARATION REDUCING UNPLEASANT TASTE AND BAD SMELL}LIQUID PREPARATION REDUCING UNPLEASANT TASTE AND BAD SMELL}

본 발명은 비타민B1에 유래하는 불쾌한 맛 및 냄새가 저감된 내복액제에 관한 것이다.The present invention relates to an oral solution having reduced unpleasant taste and odor derived from vitamin B 1 .

약물은 쓴맛, 떫은 맛이나 아린 맛 등의 불쾌한 맛을 나타내는 경우가 많아, 그대로는 복용할 수 없는 것이 많다. 또, 그 약물 고유의 불쾌한 냄새가 나는 것도 많고, 그 때문에 복용시에 불쾌감을 느끼는 것이 많다. 그래서, 복용시의 구강내에서의 불쾌한 맛이나 냄새를 저감 할 필요가 있다.Drugs often exhibit unpleasant tastes such as bitterness, astringent taste, or astringent taste, and many of them cannot be taken as they are. In addition, there are many unpleasant odors inherent in the drug, and therefore, many people feel unpleasant at the time of taking it. Therefore, it is necessary to reduce unpleasant taste and smell in the oral cavity at the time of taking.

비타민B1은 식품, 건강식품, 특정 영양식품, 의약부외품, 새로운 의약부외품, 의약품으로서 내복액제로 많이 이용되고 있는 유용한 약물이다. 그렇지만, 비타민B1은 의약부외품, 신의약부외품, 의약품 등의 제재의 활성물질로서 고농도의 내복액제로서 이용되는 경우에는 쓴맛, 떫은 맛, 아린 맛 등의 불쾌한 맛이 강해지며, 게다가 티아민취라고 하는 불쾌한 냄새도 발생하기 때문에, 복용하기 어렵다고 하는 결점이 있었다.Vitamin B 1 is a useful drug that is widely used as an oral solution for foods, health foods, specific nutritional foods, quasi-drugs, new quasi-drugs, and medicines. However, vitamin B 1 is an active substance for quasi-drugs, quasi-drugs, and medicines, and when used as a high concentration oral solution, it becomes more unpleasant such as bitterness, astringent taste, and arine taste. Since an unpleasant smell also arises, there was a fault that it was difficult to take.

비타민B1의 불쾌한 맛이나 냄새를 저감하고, 복용하기 쉽게 하기 위해서, 종래부터 여러 가지 방법이 시도되고 있으며, 예를 들면, 글루콘산염 및 유기산의 칼슘염을 배합하는 방법(특허문헌 1), 플루츠계 향료, 아세술팜칼륨 및 스테비아 추출물을 배합하는 방법(특허문헌 2), 전해질을 전기분해하여 얻어지는 전해환원수를 이용하는 방법(특허문헌 3), 전화형 액당을 첨가하여 쓴 맛을 저감하는 방법(특허문헌 4), 멘톨 및 폴리옥시에틸렌­폴리옥시 프로필렌­글리콜중 적어도 1종을 함유시키는 방법(특허문헌 5)이 알려져 있다.In order to reduce the unpleasant taste and smell of vitamin B 1 and to make it easy to take, various methods have been tried conventionally, for example, the method of mix | blending the gluconate and the calcium salt of an organic acid (patent document 1), A method of blending a flute-based perfume, acesulfame potassium and a stevia extract (Patent Document 2), a method using electrolytic reduced water obtained by electrolyzing an electrolyte (Patent Document 3), and a method of reducing the bitter taste by adding a telephone liquid sugar ( Patent document 4) and the method (patent document 5) which contain at least 1 sort (s) of menthol and polyoxyethylene polyoxy propylene glycol are known.

그렇지만, 지금까지의 비타민B1에 유래하는 불쾌한 맛이나 냄새의 마스킹 방법에서는 저농도의 비타민B1의 불쾌한 맛의 마스킹은 할 수 있어도, 고농도의 비타민B1의 불쾌한 맛의 저감 작용은 만족할 수 있는 것은 아니었다.However, having the masking method of the unpleasant taste and odor derived from vitamin B 1 in so far masking the unpleasant taste of a low concentration of vitamin B 1 which may be, reduced function of the unpleasant taste of high concentrations of vitamin B 1 is satisfied It wasn't.

또, 특히 비타민B1을 고농도 함유하는 내복액제에 있어서는 불쾌한 맛이 강할 뿐만이 아니라, 제형이 액체임으로써 비타민B1 유래의 티아민취가 강하게 느껴지기 때문에, 내복액제의 복용감이 지극히 나쁘다고 하는 문제가 있었다.In addition, especially in an oral solution containing a high concentration of vitamin B 1 , not only the unpleasant taste is strong, but also because the thiamine odor derived from vitamin B 1 is strongly felt when the formulation is a liquid, there is a problem that the taking of the oral solution is extremely bad. there was.

[특허문헌 1] 일본국 특허공개 2003-335679호 공보[Patent Document 1] Japanese Patent Publication No. 2003-335679

[특허문헌 2] 일본국 특허공개 2003-231647호 공보[Patent Document 2] Japanese Patent Publication No. 2003-231647

[특허문헌 3] 일본국 특허공개 2002-338498호 공보[Patent Document 3] Japanese Patent Application Laid-Open No. 2002-338498

[특허문헌 4] 일본국 특허공개 2002-322062호 공보[Patent Document 4] Japanese Unexamined Patent Publication No. 2002-322062

[특허문헌 5] 일본국 특허공개평 11-139992호 공보[Patent Document 5] Japanese Patent Application Laid-Open No. 11-139992

따라서, 본 발명의 과제는 비타민B1에 유래하는 불쾌한 맛 및 냄새가 저감된 비타민B1을 고농도 함유하는 내복액제을 제공하는 것에 있다.Accordingly, an object of the present invention is to provide oral aekjeeul which contains a high concentration, and the unpleasant taste of vitamin B 1 is a reduced odor originating from the vitamin B 1.

본 발명자들은 상기 과제를 해결하기 위해서 여러 가지 검토한 결과, 특정량의 이산화탄소를 내복액제에 배합시킴으로써, 고농도의 비타민B1에 유래하는 불쾌한 맛과 냄새를 효과적으로 저감할 수 있음을 발견하고, 본 발명을 완성하기에 이르렀다.The present inventors have found that the result of various investigations to solve the above problems, can be by blending the carbon dioxide a certain amount of the oral solution, effectively reducing the unpleasant taste and odor attributable to the high concentration of vitamin B 1, the present invention Came to complete.

즉, 본 발명은 비타민B1을 1㎍/mL이상 및 이산화탄소를 가스 내압으로 1.0~4.0kg/㎤ 함유하는 비타민B1에 유래하는 불쾌한 맛 및 냄새가 저감된 내복액제를 제공하는 것이다.That is, the present invention provides an oral solution having an unpleasant taste and odor derived from vitamin B 1 containing 1 μg / mL or more of vitamin B 1 and 1.0 to 4.0 kg / cm 3 of carbon dioxide at a gas internal pressure.

또, 본 발명은 비타민B1을 1㎍/mL 이상 함유하는 내복액제에 이산화탄소를 가스 내압으로 1.0~4.0kg/㎤ 함유하게 하는 비타민B1 내복액의 비타민B1에 유래하는 불쾌한 맛 및 냄새의 저감방법을 제공하는 것이다.In addition, the present invention relates to an unpleasant taste and odor derived from vitamin B 1 of the vitamin B 1 oral solution which contains 1.0 to 4.0 kg / cm 3 of carbon dioxide in an internal oral solution containing 1 μg / mL or more of vitamin B. It is to provide a reduction method.

본 발명에 의하면, 비타민B1을 고농도 함유하는 내복액제의 비타민B1에 유래하는 불쾌한 맛 및 냄새를 저감 할 수 있다. 따라서, 본 발명의 내복액제는 뛰어난 복용감 및 비타민B1이 뛰어난 약리 작용을 가지기 위해, 청량 음료, 의약부외품, 특히 의약품으로서 유용하다.According to the present invention, it is possible to reduce the unpleasant taste and odor derived from vitamin B 1 in oral liquid preparation that contains a high concentration of vitamin B 1. Therefore, the oral solution of the present invention is useful as a soft drink, quasi-drugs, and especially medicines in order to have an excellent feeling of taking and pharmacological action of vitamin B 1 .

본 발명에 있어서, 비타민B1으로서는 예를 들면, 티아민, 티아민 염산염, 티아민 질산염, 티아민디설파이드 질산염(비스티아민 질산염), 티아민디설파이드, 티아민디세틸 황산에스테르염, 디세티아민 염산염, 푸르설티아민염산염, 푸르설티아민, 옥토티아민, 시코티아민, 비스이부티아민, 비스벤티아민, 프로술티아민, 벤포티아민, 코카복실라제, 디벤조일티아민 등의 비타민B1 및 그 염과 그들의 유도체로부터 선택되는 1종 또는 2종 이상을 들 수 있다.In the present invention, as vitamin B 1 , for example, thiamin, thiamin hydrochloride, thiamin nitrate, thiamin disulfide nitrate (bistiamine nitrate), thiamin disulfide, thiamin disetyl sulfate ester salt, disetiamine hydrochloride, fursulthiamine hydrochloride, green Description thiamine, loam thiamine, Shiko thiamine, biseuyi portion thiamine, bis Ben thiamine, Pro alcohol thiamine, benpo thiamine, Coca decarboxylase, dibenzoyl one or both of thiamine vitamin B 1 and selected from the salts and derivatives of The above is mentioned.

본 발명에 있어서, 비타민B1의 함유량은 내복액제 전체에 대하여 1㎍/mL이상이지만, 10~800㎍/mL가 바람직하고, 25~800㎍/mL가 보다 바람직하고, 45~200㎍/mL가 한층 더 바람직하다.In the present invention, the content of vitamin B 1 is 1 µg / mL or more with respect to the entire oral solution, but 10-800 µg / mL is preferable, 25-800 µg / mL is more preferable, and 45-200 µg / mL Is more preferable.

본 발명에 있어서, 이산화탄소로서는 이산화탄소를 단독으로 사용해도 좋고, 이산화탄소와 그 이외의 산소, 수소, 질소 등의 가스류를 2종류 이상 혼합해도 좋지만, 이산화탄소를 단독으로 이용하는 것이 바람직하다.In the present invention, carbon dioxide may be used alone as carbon dioxide, or two or more types of gas such as oxygen, hydrogen, and nitrogen other than carbon dioxide may be mixed, but carbon dioxide is preferably used alone.

본 발명에 있어서, 이산화탄소의 함유량은 내복액 전체에 대한 가스 내압(단위 체적중에 용해하고 있는 가스량)으로서 1.0~4.0kg/㎤이지만, 2.2~3.7kg/㎤가 바람직하고, 2.5~3.5kg/㎤가 보다 바람직하고, 3.0~3.4kg/㎤가 한층 더 바람직하다.In the present invention, the carbon dioxide content is 1.0 to 4.0 kg / cm 3 as the gas internal pressure (amount of gas dissolved in the unit volume) with respect to the entire internal liquid, but 2.2 to 3.7 kg / cm 3 is preferable, and 2.5 to 3.5 kg / cm 3 Is more preferable, and 3.0-3.4 kg / cm <3> is further more preferable.

가스 내압력이 1.0kg/㎤를 밑돌면, 비타민B1에 유래하는 불쾌한 맛이나 냄새의 저감 작용을 충분히 얻을 수 없는 점에서 바람직하지 않다.If the gas internal pressure is less than 1.0 kg / cm 3, it is not preferable in that an unpleasant taste or smell reduction effect derived from vitamin B 1 cannot be sufficiently obtained.

본 발명의 내복액제의 용매로서는 물, 에탄올, 프로필렌 글리콜, 글리세린을 들 수 있다. 이 중, 물을 이용하는 것이 바람직하다.Water, ethanol, propylene glycol, glycerin are mentioned as a solvent of the internal liquid solution of this invention. Among these, it is preferable to use water.

또, 본 발명의 내복액제에는 비타민B1류 및 이산화탄소의 그 밖에도, 통상의 내복액제에 배합 가능한 성분, 예를 들면, 비타민B2, 나이아신, 판토텐산, 비타민B6, 비타민B12, 비타민C 등의 비타민류;타우린;염화 카르니틴, 시스테인 등의 아미노산류;생약, 카페인, 디클로로 초산 디이소프로필아민, 철, 칼슘 등의 미네랄류;콘드로이틴, 글루코사민,

Figure 112009073557101-PAT00001
-오리자놀, 이노시톨,
Figure 112009073557101-PAT00002
-리포산, 비오틴, 엽산, 우르소데스옥시콜인산, 로얄제리, 아스파라긴산 나트륨, 글루크로노락톤, 첨가제 등을 소망에 따라 배합할 수 있다.In addition, the oral solution of the present invention includes vitamin B 1 and carbon dioxide, as well as components that can be blended with common oral solutions, for example, vitamin B 2 , niacin, pantothenic acid, vitamin B 6 , vitamin B 12 , vitamin C, and the like. Vitamins; taurine; amino acids such as carnitine chloride, cysteine; herbals, caffeine, minerals such as dichloroacetic diisopropylamine, iron, calcium; chondroitin, glucosamine,
Figure 112009073557101-PAT00001
-Oryzanol, inositol,
Figure 112009073557101-PAT00002
Lipoic acid, biotin, folic acid, ursodesoxycholic acid, royal jelly, sodium aspartic acid, glucronolactone, and additives can be blended as desired.

상기 비타민B2로서는 예를 들면, 리보플라빈, 리보플라빈부티르산염, 인산리보플라빈나트륨, 플라빈아데닌디뉴클레오티드 등의 비타민B2 및 그 염과 그들의 유도체로부터 선택되는 1종 또는 2종 이상을 들 수가 있다. 비타민B2의 함유량은 20~240㎍/mL가 바람직하다.Examples of the vitamin B 2 include one or two or more selected from vitamin B 2 and salts thereof, such as riboflavin, riboflavin butyrate, sodium riboflavin phosphate and flavin adenine dinucleotide, and salts thereof. The content of vitamin B 2 was a 20 ~ 240㎍ / mL is preferred.

상기 나이아신으로서는 예를 들면, 니코틴산, 니코틴산아미드, 이노시톨헥사니코티네이트, 헤프로니카트 등의 나이아신 및 그 염과 그들의 유도체로부터 선택되는 1종 또는 2종 이상을 들 수가 있다. 나이아신의 함유량은 120㎍/mL~6mg/mL가 바람직하다.As said niacin, 1 type, or 2 or more types chosen from niacin, such as nicotinic acid, nicotinic acid amide, inositol hexanicotinate, hepronicate, its salt, and derivatives thereof, is mentioned, for example. As for content of niacin, 120 micrograms / mL-6 mg / mL are preferable.

상기 판토텐산으로서는 예를 들면, 판토텐산 칼슘, 판토텐산 나트륨, 판테놀, 판테틴 등의 판토텐산 및 그 염과 그들의 유도체로부터 선택되는 1종 또는 2종 이상을 들 수가 있다. 판토텐산의 함유량은 50㎍/mL~3mg/mL가 바람직하다.Examples of the pantothenic acid include one or two or more selected from pantothenic acid such as calcium pantothenate, sodium pantothenate, panthenol and panthetin, salts thereof and derivatives thereof. As for content of pantothenic acid, 50 microgram / mL-3 mg / mL are preferable.

상기 비타민B6로서는 예를 들면, 피리독신, 피리독살, 피리독사민, 피리독실 인산염, 피리독살 인산염, 인산 피리독사민 등의 비타민B6 및 그 염과 그들의 유도체로부터 선택되는 1종 또는 2종 이상을 들 수가 있다. 비타민B6의 함유량은 20㎍/mL~1mg/mL가 바람직하다.Examples of the vitamin B 6 include one or two or more selected from vitamin B 6 and salts thereof and derivatives thereof such as pyridoxine, pyridoxal, pyridoxamine, pyridoxyl phosphate, pyridoxal phosphate, and pyridoxamine phosphate. Can be mentioned. The content of the vitamin B 6 is 20㎍ / mL ~ 1mg / mL is preferred.

상기 비타민B12로서는 예를 들면, 코발라민, 시아노코발라민, 히드록소코발라민, 히드록소코발라민 아세트산염, 메코발라민 등의 비타민B12 및 그 염과 그들의 유도체로부터 선택되는 1종 또는 2종 이상을 들 수가 있다. 비타민B12의 함유량은 0.01~6㎍/mL가 바람직하다.Examples of the vitamin B 12 include one or two or more selected from vitamin B 12 and salts thereof, such as cobalamin, cyanocobalamin, hydroxylcobalamin, hydroxycobalamin acetate, and mecobalamin and derivatives thereof. have. The content of vitamin B 12 is the 0.01 ~ 6㎍ / mL is preferred.

첨가제로서는 예를 들면, 교미제, 감미제, 안정화제, 증점제, 용해 보조제, pH조절제, 착색제, 향료 등을 들 수 있다.As an additive, a mating agent, a sweetener, a stabilizer, a thickener, a dissolution aid, a pH adjuster, a coloring agent, a fragrance, etc. are mentioned, for example.

상기 교미제로서는 예를 들면, 포비돈, 멘톨, 글리실리친산 2나트륨, 말레인산, 말레인산나트륨, 타르타르산, 타르타르산나트륨, 숙신산, 숙신산나트륨, 아세트산, 글루타민산, 글루타민산나트륨, 시트르산, 시트르산나트륨, 글루코노락톤, 염화나트륨 등을 들 수 있다.As said mating agent, for example, povidone, menthol, disodium glycyric acid, maleic acid, sodium maleate, tartaric acid, sodium tartarate, succinic acid, sodium succinate, acetic acid, glutamic acid, sodium glutamate, citric acid, sodium citrate, gluconolactone, sodium chloride Etc. can be mentioned.

상기 감미제로서는 예를 들면, 자당, 과당, 포도당, 젖당, 소르비톨, 멀티톨, 에리스리톨, 크실리톨, 트레할로스, 수크랄로스, 벌꿀, 사카린, 사카린나트륨, 스테비아추출물, 아스파테임, 아세설팜칼륨, 흑사탕, 소마틴, 감초 등을 들 수 있다.As the sweetener, for example, sucrose, fructose, glucose, lactose, sorbitol, multitol, erythritol, xylitol, trehalose, sucralose, honey, saccharin, sodium saccharin, stevia extract, aspartame, acesulfame potassium, black candy, beef Martin, licorice, etc. are mentioned.

상기 안정화제로서는 예를 들면, 포비돈, 글리세린, 에리소르빈산 및 그 염, 에데트산 및 그 염, 메타인산 등을 들 수 있다.As said stabilizer, povidone, glycerin, erythorbic acid and its salt, edetic acid and its salt, metaphosphoric acid, etc. are mentioned, for example.

상기 증점제로서는 예를 들면, 카르멜로오스나트륨, 한천, 포비돈, 폴리비닐알코올, 크산탄검 등을 들 수 있다.Examples of the thickener include sodium carmellose, agar, povidone, polyvinyl alcohol, xanthan gum, and the like.

상기 용해 보조제로서는 예를 들면, 폴리소르베이트, 매크로골, 폴리옥시에틸렌경화피마자유, 포비돈, 수산화나트륨 등을 들 수 있다.Examples of the dissolution aid include polysorbate, macrogol, polyoxyethylene hardened castor oil, povidone, sodium hydroxide and the like.

상기 pH조절제로서는 예를 들면, 시트르산, 시트르산나트륨, 젖산, 수산화 나트륨, 염산, 말레인산, 말레인산나트륨, 타르타르산, 타르타르산나트륨, 숙신산, 숙신산나트륨, 초산, 글루콘산, 인산 등을 들 수 있다.Examples of the pH adjusting agent include citric acid, sodium citrate, lactic acid, sodium hydroxide, hydrochloric acid, maleic acid, sodium maleate, tartaric acid, sodium tartarate, succinic acid, sodium succinate, acetic acid, gluconic acid, and phosphoric acid.

상기 착색제로서는 예를 들면, 타르 색소, 3이산화철, 캬라멜 등을 들 수 있다.As said coloring agent, a tar pigment, iron trioxide, a caramel, etc. are mentioned, for example.

상기 향료로서는 예를 들면, 애플티 플래이버, 애프리콧티 플레이버, 로즈티플레이버, 홍차 플레이버, 애플 플래이버, 파인애플 플래이버 등을 들 수 있다.Examples of the flavors include apple tea flavor, apricot flavor, rose tea flavor, black tea flavor, apple flavor, pineapple flavor and the like.

본 발명의 내복액제의 pH로서는 비타민B1의 약리작용의 안정성을 확보하는 점에서, pH1~6이 바람직하고, pH2.0~4.5의 범위가 한층 더 바람직하다. pH조정은 종래 공지의 방법에 의해 행하면 좋고, 예를 들면 산이나 염기의 첨가에 의한다.In that it ensures the stability of the pharmacological effects of vitamin B 1 as the pH of the oral solution of the present invention, pH1 ~ 6 are preferable, and more preferably in the range of pH2.0 ~ 4.5. pH adjustment may be performed by a conventionally well-known method, for example by addition of an acid or a base.

본 발명의 내복액제는 상법의 내복액제의 제조방법에 따라 제조할 수가 있다.The oral solution of the present invention can be produced according to the method for producing an oral solution of the conventional method.

본 발명의 내복액제는 통상의 액제와 동일하게 복용할 수가 있다.The internal oral solution of the present invention can be taken in the same manner as a normal liquid.

[실시예]EXAMPLE

이하, 실시예를 들어 본 발명을 한층 더 상세하게 설명하지만, 본 발명의 범위는 이것에 한정되는 것은 아니다.Hereinafter, although an Example is given and this invention is demonstrated in more detail, the scope of the present invention is not limited to this.

제조예 1 비타민B1을 함유하는 내복액제 및 비교액제의 제조Preparation Example 1 Preparation of oral solution and comparative solution containing vitamin B 1

비타민B1(질산염) 0.4g, 1g, 2g, 10g 각각을 정제수 40L에 용해하고, 탈기처리를 행했다.0.4 g, 1 g, 2 g, and 10 g of vitamin B 1 (nitrate) were dissolved in 40 L of purified water and degassed.

다음으로, 얻어진 각각의 용액, 또는 탈기를 행한 정제수의 어느쪽이든 8L를 내압용기에 취하고, 이산화탄소를 가스 내압으로 각각, 1.2kg/㎤, 2.2kg/㎤, 3.2kg/㎤가 되도록 조정하여 압입했다. 이 액을 세정한 갈색 유리병에 충전하고, 캡핑한 것을 내복액제로 했다.Next, 8 L of each of the obtained solutions or deaerated purified water was taken into a pressure-resistant container, and carbon dioxide was adjusted to be 1.2 kg / cm 3, 2.2 kg / cm 3, and 3.2 kg / cm 3 with a gas internal pressure, respectively. . This liquid was filled in the washed brown glass bottle, and what was capped was made into the oral solution.

시험예 1Test Example 1

5명의 정상 피험자가, 제조예의 내복액제 또는 비교액제의 내복액제의 약 5mL를 입에 넣고, 삼키지 않게 주의하면서 혀에 퍼지게 하여 약 15초후에 토해냈 다. 이 때의 수렴성, 자극성, 쓴맛, 떫은맛, 아린맛 등의 불쾌한 맛의 정도와 불쾌한 냄새의 정도를 하기에 나타내는 5단계로 평가했다.Five normal subjects put about 5 mL of the oral solution of the preparation example or the comparative solution into the mouth, and spit out after about 15 seconds by spreading it on the tongue while being careful not to swallow. At this time, it evaluated in five stages which show the degree of unpleasant taste and unpleasant smell, such as astringent, irritation, bitterness, astringent taste, and astringency, at the time.

flavor

1:매우 불쾌한 맛을 느낀다1: We feel very unpleasant taste

2:불쾌한 맛을 느낀다2: We feel unpleasant taste

3:조금 불쾌한 맛을 느낀다3: We feel unpleasant taste a little

4:불쾌한 맛을 느끼는 것 같은 생각이 든다4: We feel like feeling unpleasant taste

5:아무것도 느끼지 않는다5: I do not feel anything

냄새smell

1:매우 불쾌한 냄새를 느낀다1: We feel very unpleasant smell

2:불쾌한 냄새를 느낀다2: We feel unpleasant smell

3:조금 불쾌한 냄새를 느낀다3: We feel unpleasant smell a little

4:불쾌한 냄새를 느끼는 것 같은 생각이 든다4: We feel like feeling unpleasant smell

5:아무것도 느끼지 않는다5: I do not feel anything

비타민B1을 함유하는 내복액제의 맛의 평가를 표 1, 냄새의 평가를 표 2에 나타낸다.Table 1 shows the evaluation of the taste of the oral solution containing vitamin B 1 and Table 2 shows the evaluation of the smell.

[표 1]TABLE 1


비타민B1(㎍/mL)Vitamin B 1 (㎍ / mL)
0    0 10    10 25   25 50    50 250   250
CO2(kg/㎤)


CO 2 (kg / cm 3)

0     0 5.0   5.0 2.4    2.4 1.8   1.8 1.4    1.4 1.2   1.2
1.2    1.2 5.0   5.0 4.6    4.6 2.8   2.8 2.2    2.2 2.0   2.0 2.2    2.2 5.0   5.0 4.8    4.8 4.0   4.0 4.2    4.2 4.0   4.0 3.2    3.2 5.0   5.0 4.8    4.8 4.6   4.6 4.6    4.6 4.2   4.2

[표 2] TABLE 2


비타민B1(㎍/mL)Vitamin B 1 (㎍ / mL)
0    0 10    10 25   25 50    50 250   250
CO2(kg/㎤)


CO 2 (kg / cm 3)

0     0 5.0   5.0 1.8    1.8 1.4   1.4 1.2    1.2 1.0   1.0
1.2    1.2 5.0   5.0 3.0    3.0 2.8   2.8 1.8    1.8 1.4   1.4 2.2    2.2 5.0   5.0 4.2    4.2 4.0   4.0 3.6    3.6 3.4   3.4 3.2    3.2 5.0   5.0 4.4    4.4 4.2   4.2 4.2    4.2 4.0   4.0

제조예 2 비타민B1 및 B2를 함유하는 내복액제 및 비교액제의 제조Preparation Example 2 Preparation of Internal Solution and Comparative Solution Containing Vitamin B 1 and B 2

비타민B1(질산염)과 비타민B2(인산 에스테르) 0.4g씩 합계 0.8g, 1g씩 합계 2g, 2g씩 합계 4g, 10g씩 합계 20g을 각각 정제수 40L에 용해하고, 탈기처리를 행하였다. 0.4 g of vitamin B 1 (nitrate) and 0.4 g of vitamin B 2 (phosphate ester) were dissolved in 40 L of purified water and 0.8 g in total, 2 g in total, 1 g in total, 2 g in total, 2 g in total, and 10 g in total, respectively.

다음으로, 얻어진 각각의 용액, 또는 탈기를 행한 정제수의 어느쪽이든 8L를 내압용기에 취하고, 이산화탄소를, 가스내압이 3.2kg/㎤가 되도록 조정하여 압입했다. 이 액을 세정한 갈색 유리병에 충전하고, 캡핑한 것을 내복액제로 했다.Next, 8 L of each of the obtained solutions or deaerated purified water was taken into a pressure resistant container, and carbon dioxide was adjusted to pressurize the gas to be 3.2 kg / cm 3. This liquid was filled in the washed brown glass bottle, and what was capped was made into the oral solution.

시험예 2Test Example 2

시험예 1과 동일하게 하여, 5명의 정상 피험자가, 제조예 2로 제조한 내복액제의 불쾌한 맛의 정도와 불쾌한 냄새의 정도를 평가했다.In the same manner as in Test Example 1, five normal subjects evaluated the degree of unpleasant taste and the degree of unpleasant smell of the oral solution prepared in Production Example 2.

비타민B1 및 B2를 함유하는 내복액제의 맛의 평가를 표 3, 냄새의 평가를 표 4에 나타낸다.Table 3 shows the evaluation of the taste of the oral solution containing vitamins B 1 and B 2 , and Table 4 shows the evaluation of the smell.

[표 3][Table 3]


비타민B1+비타민B2(㎍/mL)Vitamin B 1 + Vitamin B 2 (µg / mL)
0+0   0 + 0 10+10  10 + 10 25+25  25 + 25 50+50  50 + 50 250+250 250 + 250
CO2(kg/㎤)

CO 2 (kg / cm 3)
0     0 5.0   5.0 2.0   2.0 1.4   1.4 1.2   1.2 1.0   1.0
3.2    3.2 5.0   5.0 4.8   4.8 4.6   4.6 4.4   4.4 4.2   4.2

[표 4][Table 4]


비타민B1+비타민B2(㎍/mL)Vitamin B 1 + Vitamin B 2 (µg / mL)
0+0   0 + 0 10+10  10 + 10 25+25  25 + 25 50+50  50 + 50 250+250 250 + 250
CO2(kg/㎤)

CO 2 (kg / cm 3)
0     0 5.0   5.0 1.8   1.8 1.6   1.6 1.4   1.4 1.2   1.2
3.2    3.2 5.0   5.0 4.6   4.6 4.6   4.6 4.4   4.4 4.4   4.4

제조예 3 비타민B1 및 B6를 함유하는 내복액제 및 비교액제의 제조Preparation Example 3 Preparation of Internal Solution and Comparative Solution Containing Vitamin B 1 and B 6

비타민B1(질산염)과 비타민B6(염산염) 0.4g씩 합계 0.8g, 1g씩 합계 2g, 2g씩 합계 4g, 10g씩 합계 20g를, 각각 정제수 40L에 용해하고, 탈기처리를 행했다.In total, 0.4 g of vitamin B 1 (nitrate) and 0.4 g of vitamin B 6 (hydrochloride) were dissolved in 40 L of purified water, respectively, in total of 0.8 g, 1 g in total, 2 g in total, 2 g in total, 4 g in total, and 10 g in total.

다음으로, 얻어진 각각의 용액, 또는 탈기를 행한 정제수의 어느쪽이든 8L를 내압 용기에 취하고, 이산화탄소를 가스 내압이 3.2kg/㎤가 되도록 조정하여 압입했다. 이 액을 세정한 갈색 유리병에 충전하고, 캡핑한 것을 내복액제로 했다.Next, either 8 L of each of the obtained solutions or deaerated purified water was taken into a pressure-resistant container, and carbon dioxide was adjusted to pressurize the gas to be 3.2 kg / cm 3. This liquid was filled in the washed brown glass bottle, and what was capped was made into the oral solution.

시험예 3Test Example 3

시험예 1과 동일하게 하고, 5명의 정상 피험자가, 제조예 3으로 제조한 내복액제의 불쾌한 맛의 정도와 불쾌한 냄새의 정도를 평가했다.In the same manner as in Test Example 1, five normal subjects evaluated the degree of unpleasant taste and the degree of unpleasant smell of the oral solution prepared in Production Example 3.

비타민B1 및 B6를 함유하는 내복액제의 맛의 평가를 표 5, 냄새의 평가를 표 6에 나타낸다.Table 5 shows evaluation of the taste of the oral solution containing vitamins B 1 and B 6 and Table 6 shows the evaluation of the smell.

[표 5]TABLE 5


비타민B1+비타민B6(㎍/mL)Vitamin B 1 + Vitamin B 6 (µg / mL)
0+0   0 + 0 10+10  10 + 10 25+25  25 + 25 50+50  50 + 50 250+250 250 + 250
CO2(kg/㎤)

CO 2 (kg / cm 3)
0     0 5.0   5.0 2.4   2.4 1.8   1.8 1.4   1.4 1.0   1.0
3.2    3.2 5.0   5.0 4.8   4.8 4.8   4.8 4.6   4.6 4.6   4.6

[표 6]TABLE 6


비타민B1+비타민B6(㎍/mL)Vitamin B 1 + Vitamin B 6 (µg / mL)
0+0   0 + 0 10+10  10 + 10 25+25  25 + 25 50+50  50 + 50 250+250 250 + 250
CO2(kg/㎤)

CO 2 (kg / cm 3)
0     0 5.0   5.0 2.2   2.2 1.8   1.8 1.6   1.6 1.2   1.2
3.2    3.2 5.0   5.0 4.6   4.6 4.6   4.6 4.4   4.4 4.2   4.2

제조예 4 비타민B1, B2 및 B6를 함유하는 내복액제 및 비교액제의 제조Preparation Example 4 Preparation of Internal Solution and Comparative Solution Containing Vitamin B 1 , B 2 and B 6

비타민B1(질산염), 비타민B2(인산 에스테르), 비타민B6(염산염) 0.4g씩 합계 1.2g, 1g씩 합계 3g, 2g씩 합계 6g, 10g씩 합계 30g를 각각 정제수 40L에 용해하고, 탈기처리를 행했다.Dissolve 1.2 g of vitamin B 1 (nitrate), vitamin B 2 (phosphate ester), and vitamin B 6 (hydrochloride) in total of 1.2 g, 1 g in total of 3 g, 2 g in total of 6 g, and 10 g in total of 30 g in 40 L of purified water, Degassing treatment was performed.

다음으로, 얻어진 각각의 용액, 또는 탈기를 실시한 정제수의 8L 어느쪽이든 내압 용기에 취하고, 이산화탄소를 가스 내압이 3. 2kg/㎤가 되도록 조정하여 압입했다. 이 액을 세정한 갈색 유리병에 충전하여, 캡핑한 것을 내복액제로 했다.Next, either 8 L of each of the obtained solutions or deaerated purified water was taken into a pressure-resistant container, and carbon dioxide was adjusted to pressurize to a gas internal pressure of 3.2 kg / cm 3. This solution was filled in the washed brown glass bottle, and what was capped was used as an internal oral solution.

비타민B1, B2 및 B6를 함유하는 내복액제의 맛의 평가를 표 7, 냄새의 평가를 표 8에 나타낸다.Table 7 shows the evaluation of the taste of the oral solution containing vitamins B 1 , B 2 and B 6 , and Table 8 shows the evaluation of the smell.

[표 7]TABLE 7


비타민B1+B2+B6(㎍/mL)Vitamin B 1 + B 2 + B 6 (µg / mL)
0+0+0   0 + 0 + 0 10+10+10  10 + 10 + 10 25+25+25 25 + 25 + 25 50+50+50  50 + 50 + 50 250+250+250 250 + 250 + 250
CO2(kg/㎤)

CO 2 (kg / cm 3)
0    0 5.0   5.0 1.8   1.8 1.2   1.2 1.0   1.0 1.0   1.0
3.2   3.2 5.0   5.0 4.8   4.8 4.6   4.6 4.4   4.4 4.2   4.2

[표 8][Table 8]


비타민B1+B2+B6(㎍/mL)Vitamin B 1 + B 2 + B 6 (µg / mL)
0+0+0   0 + 0 + 0 10+10+10  10 + 10 + 10 25+25+25  25 + 25 + 25 50+50+50  50 + 50 + 50 250+250+250 250 + 250 + 250
CO2(kg/㎤)

CO 2 (kg / cm 3)
0    0 5.0   5.0 2.0   2.0 1.4   1.4 1.2   1.2 1.0   1.0
3.2   3.2 5.0   5.0 4.8   4.8 4.8   4.8 4.2   4.2 4.0   4.0

Claims (2)

비타민B1을 1㎍/mL이상 및 이산화탄소를 가스 내압으로 1.0~4.0kg/㎤ 함유하는 비타민B1에 유래하는 불쾌한 맛 및 냄새가 저감된 내복액제.An oral solution containing unpleasant taste and odor derived from vitamin B 1 containing 1 μg / mL or more of vitamin B 1 and 1.0 to 4.0 kg / cm 3 of carbon dioxide at a gas internal pressure. 비타민B1을 1㎍/mL이상 함유하는 내복액제에, 이산화탄소를 가스 내압으로 1.0~4.0kg/㎤ 함유하게 하는 비타민B1 내복액의 비타민B1에 유래하는 불쾌한 맛 및 냄새의 저감방법.A method of reducing unpleasant taste and odor derived from vitamin B 1 of a vitamin B 1 oral solution which contains 1.0 to 4.0 kg / cm 3 of carbon dioxide in an internal oral solution containing 1 μg / mL or more of vitamin B 1 .
KR1020090116597A 2008-12-22 2009-11-30 Liquid preparation reducing unpleasant taste and bad smell KR20100073987A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP-P-2008-325880 2008-12-22
JP2008325880A JP5688205B2 (en) 2008-12-22 2008-12-22 An oral solution with reduced unpleasant taste and odor

Publications (1)

Publication Number Publication Date
KR20100073987A true KR20100073987A (en) 2010-07-01

Family

ID=42488371

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090116597A KR20100073987A (en) 2008-12-22 2009-11-30 Liquid preparation reducing unpleasant taste and bad smell

Country Status (4)

Country Link
JP (1) JP5688205B2 (en)
KR (1) KR20100073987A (en)
CN (1) CN101756885A (en)
TW (1) TW201023768A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210110450A (en) 2020-02-28 2021-09-08 주식회사 종근당 Multi-vitamins complex composition with improved compliance and preparation method for the same
KR102622231B1 (en) 2022-07-01 2024-01-08 주식회사 종근당 PHARMACEUTICAL COMPOSITION OF MULTI-VITAMINS COMPLEX FOR IMPROVING APPEARANCE STABILITY USING iSTab(innovative Stability Technology by antimoisture barrier) TECHNOLOGY

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7279328B2 (en) * 2017-10-04 2023-05-23 大正製薬株式会社 drinking composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63273460A (en) * 1986-12-26 1988-11-10 Toyo Seikan Kaisha Ltd Production of beverage containing small quantity of gaseous carbon dioxide
EP0511587A1 (en) * 1991-04-26 1992-11-04 Takeda Chemical Industries, Ltd. Slimming composition
JP4216916B2 (en) * 1997-11-10 2009-01-28 大正製薬株式会社 Drinking liquid composition
JPH11318402A (en) * 1998-05-11 1999-11-24 Kikkoman Corp Refreshing drinkable preparation
JP2000004852A (en) * 1998-06-24 2000-01-11 Sapporo Breweries Ltd Low-caloric carbonated drink
JP3901374B2 (en) * 1998-12-25 2007-04-04 株式会社ヤクルト本社 Acidic drinking liquid composition
JP2001095541A (en) * 1999-10-01 2001-04-10 Yakult Honsha Co Ltd Bittered carbonated beverage
CN1315149A (en) * 2000-03-29 2001-10-03 云南文山华文企业集团三七产业高科技开发中心 Notoginseng sweet dew
US20040018275A1 (en) * 2002-07-23 2004-01-29 Unilever Bestfoods Carbonated energy beverage
JP4418702B2 (en) * 2004-04-19 2010-02-24 小川香料株式会社 Method for preventing the generation of off-flavor components in an acidic drinking composition containing vitamin B1 or a derivative thereof
JP4768667B2 (en) * 2006-06-16 2011-09-07 花王株式会社 Container drink
JP5080835B2 (en) * 2006-07-04 2012-11-21 花王株式会社 Effervescent container beverage

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210110450A (en) 2020-02-28 2021-09-08 주식회사 종근당 Multi-vitamins complex composition with improved compliance and preparation method for the same
KR102622231B1 (en) 2022-07-01 2024-01-08 주식회사 종근당 PHARMACEUTICAL COMPOSITION OF MULTI-VITAMINS COMPLEX FOR IMPROVING APPEARANCE STABILITY USING iSTab(innovative Stability Technology by antimoisture barrier) TECHNOLOGY

Also Published As

Publication number Publication date
TW201023768A (en) 2010-07-01
JP2010143894A (en) 2010-07-01
CN101756885A (en) 2010-06-30
JP5688205B2 (en) 2015-03-25

Similar Documents

Publication Publication Date Title
KR20100135316A (en) Liquid formulation for deferiprone with palatable taste
KR100472590B1 (en) Oral Intake Solution
KR20100073987A (en) Liquid preparation reducing unpleasant taste and bad smell
KR101326397B1 (en) Liquid medicine for internal use
JP3202282B2 (en) Beverages containing B vitamins
JP2002080369A (en) Thiamine derivative-containing composition
JPH07227256A (en) Liquid agent for oral administration
JP6096550B2 (en) Oral composition
JP2002348236A (en) Liquid drug
JP4373649B2 (en) Oral solution
JP2007153833A (en) Oral administration composition
JP4216916B2 (en) Drinking liquid composition
JP4959864B2 (en) Glutamate-containing solution
JPH11171793A (en) Solution containing vitamin b1s formulated therein
KR100825572B1 (en) Liquid Formulation Containing Calcium, Magnesium and Vitamin, and Preparing Method Thereof
JP4929629B2 (en) Zinc-containing composition for oral administration
JP4321193B2 (en) Carrot combination liquid composition
JP4206506B2 (en) Solution containing vitamin B1
JP4248795B2 (en) Liquid for internal use
JP6114133B2 (en) Kokushi extract-containing oral solution, solubilizer and solubilization method
JPH07112933A (en) Stable conjugated vitamin solution for internal use
KR102342514B1 (en) A pharmaceutical composition in the form of an aqueous solution for oral administration comprising magnesium glycerophosphate
JP2000239153A (en) Internal medicine composition containing iron compound
JP4228403B2 (en) Solution containing vitamin B1
JP2011231051A (en) Oral jelly preparation containing vitamin b1

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination